interview
collect
serum
specimen
avail
member
initi
outbreak
admit
focal
outbreak
hospit
period
march
april
fever
dri
cough
radiolog
evid
pneumonia
household
contact
report
usual
sleep
roof
defin
outbreak
member
sampl
healthcar
personnel
medic
institut
admit
outbreak
subject
nonsystemat
enrol
prefer
toward
report
close
contact
outbreak
member
field
investig
jmoh
hospit
subject
meet
initi
outbreak
case
definit
subsequ
transfer
focal
outbreak
hospit
hospit
amman
particip
healthcar
personnel
employ
one
hospit
jmoh
epidemiolog
data
obtain
medic
record
review
person
interview
may
investig
interview
conduct
arab
document
contact
histori
outbreak
member
household
member
visit
travel
anim
occup
exposur
conduct
medic
record
review
key
inform
interview
clinician
provid
medic
care
patient
suspect
infect
head
infect
control
unit
medic
institut
jmoh
inform
consent
obtain
prior
serum
collect
interview
public
health
respons
diseas
outbreak
investig
requir
institut
review
board
review
work
live
merscov
done
cdc
biosafeti
level
contain
facil
atlanta
georgia
serum
sampl
inactiv
use
rad
store
use
maxim
specif
defin
merscov
antibodi
posit
subject
correl
posit
laboratori
result
screen
enzymelink
immunosorb
assay
elisa
well
confirm
posit
result
either
merscov
immunofluoresc
assay
ifa
merscov
microneutr
assay
mnt
supplementari
tabl
initi
indetermin
test
result
record
subject
singl
uncorrel
posit
test
result
genet
sequenc
data
indic
merscov
subgroup
similar
bat
cov
recombin
nucleocapsid
elisa
develop
cdc
detect
presenc
antibodi
crossreact
n
protein
serum
sampl
possibl
mer
case
crossreact
antibodi
detect
serum
sampl
confirm
mersspecif
antibodi
determin
either
merscov
mnt
ifa
pibatcov
nucleocapsid
n
gene
plasmid
provid
dr
susanna
lau
univers
hong
kong
histag
recombin
protein
express
escherichia
coli
purifi
metal
affin
chromatographi
recombin
protein
indirect
elisa
develop
use
modifi
version
sever
acut
respiratori
syndrom
sar
cov
n
elisa
describ
hayn
et
al
sera
consid
posit
optic
densiti
od
valu
cutoff
valu
mean
absorb
nm
sera
us
blood
donor
plu
standard
deviat
overal
specif
assay
determin
screen
serum
sampl
donor
unit
state
middl
east
person
nonmer
respiratori
infect
eg
human
coronaviru
hcov
sarscov
rhinoviru
human
metapneumoviru
assay
specif
serum
human
serum
avail
evalu
howev
mous
hyperimmun
serum
crossreact
n
protein
screen
dilut
sera
od
valu
near
cutoff
titer
serial
dilut
evalu
use
merscov
genbank
ifa
mnt
indirect
immunofluoresc
perform
screen
sera
dilut
paraformaldehydefix
control
vero
cell
sourc
posit
control
assay
serum
sampl
patient
infect
merscov
provid
zambon
public
health
england
antihuman
immunoglobulin
ig
g
igm
iga
fluorescein
isothiocyan
conjug
use
specif
fluoresc
detect
immunofluoresc
microscop
posit
result
score
fluoresc
intens
equal
higher
posit
control
weakli
posit
result
score
fluoresc
intens
lower
posit
control
serum
sampl
test
presenc
neutral
antibodi
merscov
use
modifi
mnt
method
describ
sarscov
neutral
titer
measur
reciproc
highest
serum
dilut
complet
inhibit
vero
cell
monolay
lysi
least
triplic
well
control
includ
mnt
assay
perform
includ
input
viru
back
titrat
mockinfect
cell
assay
result
confirm
separ
assay
repres
data
present
test
statist
signific
perform
merscov
subject
includ
fisher
exact
test
test
categor
variabl
use
sa
softwar
version
sa
institut
cari
north
carolina
obtain
specimen
data
total
healthcar
personnel
work
repres
major
intens
care
intens
care
unit
icu
coronari
care
unit
ccu
personnel
outbreak
hospit
well
personnel
close
contact
initi
outbreak
investig
member
figur
includ
surviv
outbreak
member
healthcar
personnel
focal
outbreak
hospit
lost
followup
personnel
focal
outbreak
hospit
personnel
transfer
hospit
personnel
transfer
hospit
b
jmoh
outbreak
investig
healthcar
personnel
focal
outbreak
hospit
surviv
die
case
merscov
investig
provid
evid
merscov
infect
transmiss
event
among
personnel
receiv
transfer
hospit
even
though
patient
transfer
tempor
close
symptom
onset
date
interview
surviv
subject
famili
member
reveal
transmiss
opportun
among
healthcar
personnel
restrict
workplac
obtain
serolog
specimen
member
household
includ
initi
outbreak
group
anoth
subject
resid
outbreak
member
household
outbreak
period
one
household
lost
followup
consent
particip
one
household
symptomat
wife
initi
outbreak
investig
member
test
posit
merscov
antibodi
twelv
household
subject
children
year
old
serolog
test
neg
summari
underli
condit
testposit
subject
includ
fatal
case
initi
identifi
rrtpcr
outbreak
member
present
tabl
testposit
subject
male
median
age
year
rang
year
ill
onset
found
evid
underli
immunodefici
immunosuppress
medicationstherapi
among
subject
one
subject
atrial
septal
defect
histori
hypertens
smoker
time
ill
report
pregnanc
month
gestat
although
diabet
mellitu
observ
potenti
risk
factor
merscov
none
subject
report
prior
diagnosi
diabet
mellitu
base
serum
glucos
valu
taken
hospit
none
indic
undiagnos
diabet
mellitu
common
present
symptom
document
medic
chart
includ
fever
cough
dyspnea
chest
pain
malais
eight
subject
present
hospit
care
median
day
symptom
onset
rang
day
patient
cough
document
fever
temperatur
dyspnea
chest
pain
malais
point
diseas
cours
less
common
symptom
includ
chill
wheez
diarrhea
vomit
sore
throat
palpit
confus
seven
subject
abnorm
chest
radiograph
find
report
within
day
present
bilater
find
remain
subject
initi
unilater
find
went
develop
bilater
infiltr
later
hospit
document
either
chest
radiographi
comput
tomographi
ct
one
subject
outbreak
member
receiv
initi
diagnosi
pericard
ct
scan
abnorm
pulmonari
find
report
day
later
tabl
seven
subject
present
medic
care
admit
refus
admiss
six
subject
requir
respiratori
support
least
supplement
oxygen
subject
receiv
intens
care
ccu
icu
patient
die
requir
mechan
ventil
patient
also
requir
pressor
support
dopamin
norepinephrin
cardiorespiratori
failur
complic
among
hospit
subject
also
limit
patient
die
hyperkalemia
associ
ventricular
tachycardia
dissemin
intravascular
coagul
eventu
cardiac
arrest
pericard
pericardi
pleural
effus
supraventricular
tachycardia
late
cours
ill
although
leukopenia
observ
subject
lymphopenia
observ
subject
document
complet
blood
count
differenti
elev
leukocyt
count
observ
cours
subject
die
subject
also
laboratori
abnorm
consist
multiorgan
system
failur
late
cours
diseas
includ
evid
elev
alanin
aminotransferas
aspart
aminotransferas
ul
signific
coagulopathi
intern
normal
ratio
well
thrombocytopenia
addit
subject
die
elev
serum
creatinin
measur
day
death
third
case
isol
elev
creatinin
measur
subsequ
normal
valu
follow
day
patient
receiv
hemodialysi
tabl
outbreak
member
die
day
onset
symptom
day
hospit
outbreak
member
die
day
onset
symptom
day
hospit
remain
subject
surviv
hospit
discharg
follow
median
day
rang
day
despit
respiratori
symptom
pregnant
household
subject
seek
medic
care
due
concern
regard
receiv
chest
radiographi
medic
pregnanc
result
stillbirth
cours
ill
surviv
subject
famili
member
deceas
patient
report
contact
anim
rare
urban
area
contact
camel
identifi
among
subject
earli
symptom
onset
furthermor
none
subject
travel
receiv
visitor
arabian
peninsula
shortli
prior
symptom
onset
focal
outbreak
hospit
physic
barrier
ccu
icu
bed
space
approxim
meter
except
cloth
drape
ccu
isol
negativepressur
room
present
infect
control
complianc
issu
report
outbreak
infect
control
insuffici
note
receiv
transfer
hospit
use
novel
serolog
assay
determin
antibodi
respons
subject
merscov
outbreak
investig
jordan
includ
earliest
case
emerg
viru
yet
discov
addit
fatal
case
confirm
rrtpcr
report
discov
previous
unconfirm
unreport
merscov
infect
detect
addit
antibodyposit
subject
includ
healthcar
personnel
focal
outbreak
hospit
famili
contact
antibodyposit
subject
establish
contact
merscov
infect
subject
potenti
infecti
suggest
humantohuman
transmiss
merscov
occur
although
commun
exposur
possibl
healthcareassoci
transmiss
plausibl
explan
healthcar
personnel
infect
merscov
infect
detect
among
healthcar
personnel
transfer
hospit
better
adher
infect
control
measur
compar
publish
descript
saudi
arabian
french
case
among
total
jordanian
case
identifi
collabor
investig
subject
younger
fewer
underli
medic
condit
lower
casefat
rate
although
subject
merscov
infect
investig
acut
respiratori
ill
outbreak
period
infect
surviv
subject
underli
medic
condit
none
hemodialysi
indic
diabet
mellitu
one
newli
detect
subject
household
contact
seek
medic
care
data
support
probabl
outbreak
set
infect
may
remain
undetect
among
subject
mild
symptom
lack
predispos
condit
barrier
access
appropri
diagnost
care
therefor
true
merscov
casefat
rate
may
lower
base
symptomat
hospit
case
alon
present
symptom
observ
larg
consist
previous
describ
merscov
case
includ
fever
respiratori
symptom
cough
dyspnea
associ
infiltr
chest
radiographi
initi
present
mani
subject
evid
bilater
pneumonia
although
gastrointestin
symptom
vomit
diarrhea
document
subject
observ
present
symptom
saudi
arabian
french
case
hospit
lymphopenia
promin
laboratori
featur
among
previous
describ
case
observ
major
subject
howev
laboratori
abnorm
observ
previou
report
thrombocytopenia
limit
mostli
fatal
case
late
cours
ill
consist
multiorgan
system
failur
also
unlik
previous
report
case
renal
failur
promin
clinic
featur
among
subject
renal
dysfunct
observ
fatal
case
day
death
rapid
isol
patient
suspect
merscov
rigor
infect
control
practic
receiv
transfer
hospit
may
import
prevent
transmiss
locat
hospit
establish
polici
procedur
rapid
identif
suspect
known
merscov
case
implement
appropri
infect
prevent
measur
cdc
recommend
standard
contact
airborn
precaut
manag
hospit
patient
known
suspect
merscov
infect
one
jordanian
patient
initi
hospit
pericard
manifest
similar
merscov
case
occur
kingdom
saudi
arabia
although
jordanian
patient
serolog
specimen
test
neg
merscov
antibodi
period
throughout
hospit
stay
acut
specimen
collect
sever
day
death
confirm
posit
viru
rrtpcr
laboratori
find
patient
exposur
ccu
situat
bed
directli
next
anoth
patient
merscov
collect
suggest
likelihood
patient
nosocomi
infect
merscov
die
antibodi
respons
detect
base
knowledg
sarscov
antibodi
respons
igg
neutral
antibodi
sarscov
peak
month
follow
patient
recoveri
acut
infect
antibodi
level
declin
time
detect
sarscov
neutral
antibodi
persist
year
onset
sarscov
symptom
approxim
month
pass
may
investig
april
outbreak
although
suffici
time
infect
subject
produc
antibodi
respons
merscov
role
wane
immun
antibodi
respons
whether
persist
antibodi
import
protect
reinfect
remain
unclear
implement
rigor
case
definit
base
elisaposit
result
plu
least
correl
assay
result
maxim
specif
infect
sarscov
trigger
humor
cellular
immun
respons
studi
human
high
titer
neutral
antibodi
observ
respons
sarscov
infect
characterist
merscov
immunolog
respons
remain
unknown
indetermin
laboratori
find
among
subject
document
merscov
exposur
elisaposit
result
mild
absent
respiratori
symptom
possibl
viral
exposur
subject
trigger
longlast
ifa
mntrecogniz
immun
respons
obtain
appropri
lower
respiratori
specimen
subject
mild
asymptomat
infect
challeng
use
serolog
assay
identifi
otherwis
undetect
case
merscov
demonstr
use
tool
serolog
survey
conduct
retrospect
case
investig
around
instanc
merscov
import
europ
well
establish
estim
merscov
seropreval
among
popul
risk
valid
serolog
assay
assess
complement
rrtpcr
test
need
investig
unabl
find
evid
exposur
either
zoonot
contact
human
contact
arabian
peninsula
among
hospit
contact
preced
earliest
symptomat
case
might
explain
origin
viru
precis
rout
merscov
transmiss
remain
unclear
overal
sever
merscov
sequenc
identifi
dromedari
camel
nasal
secret
includ
one
indistinguish
found
infect
human
conclus
jordan
respiratori
ill
outbreak
april
result
total
testposit
merscov
subject
sourc
viru
earliest
known
merscov
case
remain
unknown
compar
report
improv
surviv
observ
perhap
relat
youth
rel
lack
underli
ill
among
subject
investig
infect
control
practic
transfer
receiv
hospit
may
import
prevent
merscov
transmiss
facil
sinc
discoveri
merscov
enhanc
surveil
sever
acut
respiratori
ill
jordan
implement
intern
sever
acut
respiratori
infect
surveil
collabor
investig
vigil
among
healthcar
provid
necessari
compon
address
prevent
spread
merscov
worldwid
